First-line treatment of patients with disseminated poorly differentiated neuroendocrine carcinomas with carboplatin, etoposide, and vincristine: a single institution experience

Ingrid Holst Olsen; Seppo W Langer; Ida Jepsen; Maria Assens; Birgitte Federspiel; Jane Preuss Hasselby; Carsten Palnaes Hansen; Andreas Kjaer; Ulrich Knigge

doi:10.3109/0284186X.2011.582881

First-line treatment of patients with disseminated poorly differentiated neuroendocrine carcinomas with carboplatin, etoposide, and vincristine: a single institution experience

Ingrid Holst Olsen, Seppo W Langer, Ida Jepsen, Maria Assens, Birgitte Federspiel, Jane Preuss Hasselby, Carsten Palnaes Hansen, Andreas Kjaer, Ulrich Knigge

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

15 Citationer (Scopus)

Abstract

Poorly differentiated neuroendocrine carcinomas (PDECs) represent highly malignant tumors with an immense tendency to metastasize and with a poor prognosis. The treatment consists of palliative chemotherapy and corresponds to the treatment of extensive stage small cell lung cancer.

Originalsprog	Engelsk
Tidsskrift	Acta Oncologica
Vol/bind	51
Udgave nummer	1
Sider (fra-til)	97-100
Antal sider	4
ISSN	0284-186X
DOI	https://doi.org/10.3109/0284186X.2011.582881
Status	Udgivet - 2012

Adgang til dokumentet

10.3109/0284186X.2011.582881

Citationsformater

Olsen, I. H., Langer, S. W., Jepsen, I., Assens, M., Federspiel, B., Hasselby, J. P., Hansen, C. P., Kjaer, A., & Knigge, U. (2012). First-line treatment of patients with disseminated poorly differentiated neuroendocrine carcinomas with carboplatin, etoposide, and vincristine: a single institution experience. Acta Oncologica, 51(1), 97-100. https://doi.org/10.3109/0284186X.2011.582881

First-line treatment of patients with disseminated poorly differentiated neuroendocrine carcinomas with carboplatin, etoposide, and vincristine: a single institution experience. / Olsen, Ingrid Holst; Langer, Seppo W; Jepsen, Ida et al.
I: Acta Oncologica, Bind 51, Nr. 1, 2012, s. 97-100.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

Olsen, IH, Langer, SW, Jepsen, I, Assens, M, Federspiel, B, Hasselby, JP, Hansen, CP, Kjaer, A & Knigge, U 2012, 'First-line treatment of patients with disseminated poorly differentiated neuroendocrine carcinomas with carboplatin, etoposide, and vincristine: a single institution experience', Acta Oncologica, bind 51, nr. 1, s. 97-100. https://doi.org/10.3109/0284186X.2011.582881

@article{d1a355e469854837a219a7723e03991a,

title = "First-line treatment of patients with disseminated poorly differentiated neuroendocrine carcinomas with carboplatin, etoposide, and vincristine: a single institution experience",

abstract = "Poorly differentiated neuroendocrine carcinomas (PDECs) represent highly malignant tumors with an immense tendency to metastasize and with a poor prognosis. The treatment consists of palliative chemotherapy and corresponds to the treatment of extensive stage small cell lung cancer.",

author = "Olsen, {Ingrid Holst} and Langer, {Seppo W} and Ida Jepsen and Maria Assens and Birgitte Federspiel and Hasselby, {Jane Preuss} and Hansen, {Carsten Palnaes} and Andreas Kjaer and Ulrich Knigge",

year = "2012",

doi = "10.3109/0284186X.2011.582881",

language = "English",

volume = "51",

pages = "97--100",

journal = "Acta Oncologica",

issn = "0284-186X",

publisher = "Taylor & Francis",

number = "1",

}

TY - JOUR

T1 - First-line treatment of patients with disseminated poorly differentiated neuroendocrine carcinomas with carboplatin, etoposide, and vincristine: a single institution experience

AU - Olsen, Ingrid Holst

AU - Langer, Seppo W

AU - Jepsen, Ida

AU - Assens, Maria

AU - Federspiel, Birgitte

AU - Hasselby, Jane Preuss

AU - Hansen, Carsten Palnaes

AU - Kjaer, Andreas

AU - Knigge, Ulrich

PY - 2012

Y1 - 2012

N2 - Poorly differentiated neuroendocrine carcinomas (PDECs) represent highly malignant tumors with an immense tendency to metastasize and with a poor prognosis. The treatment consists of palliative chemotherapy and corresponds to the treatment of extensive stage small cell lung cancer.

AB - Poorly differentiated neuroendocrine carcinomas (PDECs) represent highly malignant tumors with an immense tendency to metastasize and with a poor prognosis. The treatment consists of palliative chemotherapy and corresponds to the treatment of extensive stage small cell lung cancer.

U2 - 10.3109/0284186X.2011.582881

DO - 10.3109/0284186X.2011.582881

M3 - Journal article

C2 - 21615243

SN - 0284-186X

VL - 51

SP - 97

EP - 100

JO - Acta Oncologica

JF - Acta Oncologica

IS - 1

ER -